These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23588770)

  • 1. ACP Journal Club: review: antibiotics reduce treatment failure in acute chronic obstructive pulmonary disease exacerbations.
    Stanbrook MB
    Ann Intern Med; 2013 Apr; 158(8):JC5. PubMed ID: 23588770
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Review: Inhaled corticosteroids do not reduce mortality but increase pneumonia in chronic obstructive pulmonary disease.
    Rees PJ
    Ann Intern Med; 2009 Mar; 150(6):JC3-6. PubMed ID: 19306488
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease.
    Stanbrook MB
    Ann Intern Med; 2009 Jan; 150(2):JC1-6, JC1-7. PubMed ID: 19172711
    [No Abstract]   [Full Text] [Related]  

  • 4. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
    Berim I; Sethi S
    Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antibiotics in the management of chronic obstructive pulmonary disease.
    Black PN
    Expert Rev Respir Med; 2008 Apr; 2(2):235-43. PubMed ID: 20477251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis.
    Arandjus C; Black PN; Poole PJ; Wood Baker R; Steurer-Stey C
    Respir Med; 2006 Oct; 100(10):1671-81. PubMed ID: 16934969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACP Journal Club. Review: oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD.
    Ram FS
    Ann Intern Med; 2011 Sep; 155(6):JC3-2. PubMed ID: 21930839
    [No Abstract]   [Full Text] [Related]  

  • 8. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
    Black PN; McDonald CF
    Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease].
    Cavassini M; Calandra T; Bridevaux PO
    Rev Med Suisse; 2007 Apr; 3(106):939-42. PubMed ID: 17575969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation of chronic obstructive pulmonary disease.
    Ismail TS
    Med J Malaysia; 2009 Sep; 64(3):250-5; quiz 256. PubMed ID: 20527283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral infections in patients with chronic obstructive pulmonary disease.
    Varkey JB; Varkey B
    Curr Opin Pulm Med; 2008 Mar; 14(2):89-94. PubMed ID: 18303415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Sethi S
    Semin Respir Crit Care Med; 2005 Apr; 26(2):192-203. PubMed ID: 16088436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteria.
    Nseir S; Ader F
    Curr Opin Pulm Med; 2008 Mar; 14(2):95-100. PubMed ID: 18303416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease.
    Pietila MP; Thomas CF
    Semin Respir Infect; 2003 Mar; 18(1):9-16. PubMed ID: 12652449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health status and costs of exacerbations of chronic bronchitis and COPD: how to improve antibiotic treatment.
    Miravitlles M
    Expert Rev Pharmacoecon Outcomes Res; 2005 Aug; 5(4):423-35. PubMed ID: 19807260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease.
    Diederen BM; van der Valk PD; Kluytmans JA; Peeters MF; Hendrix R
    Eur Respir J; 2007 Aug; 30(2):240-4. PubMed ID: 17459899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP Journal Club: review: antiplatelet therapy does not reduce mortality in chronic kidney disease.
    Jaar BG
    Ann Intern Med; 2012 Aug; 157(4):JC2-8. PubMed ID: 22910962
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.
    Martinez FJ; Han MK; Flaherty K; Curtis J
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):101-24. PubMed ID: 16441213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries: When are antibiotics indicated for acute COPD exacerbations?
    Balser E; Neher JO; Safranek S; Taraday J
    J Fam Pract; 2006 Dec; 55(12):1079-80. PubMed ID: 17137546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.
    Murphy TF
    Curr Opin Infect Dis; 2006 Jun; 19(3):225-30. PubMed ID: 16645482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.